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Abstract
When pH and temperature of simulated body fluid (SBF) are raised, fine particles of cal-
cium phosphate are precipitated. Recently, the authors’ research group found that these 
fine particles were highly active to induce formation of porous bone-like apatite in SBF, 
or body fluid, and named them ‘apatite nuclei.’ By using apatite nuclei, the author suc-
cessfully imparted high bioactivity, that is, apatite-forming ability, to various kinds of 
bioinert biomaterials such as metals and organic polymers in a series of recent studies. 
These materials spontaneously formed porous bone-like apatite layer on their surfaces 
in SBF in a short time and showed high bioactivity in vitro. In addition, thWe author 
also successfully fabricated microcapsules consisted of porous bone-like apatite by using 
apatite nuclei.
Keywords: porous bone-like apatite, apatite nuclei, bioactive metals, bioactive organic 
polymers, apatite microcapsules
1. Introduction
1.1. Bioactive materials
When artificial materials such as metals, ceramics and organic polymers are implanted in 
the body, these materials are generally encapsulated with noncalcified fibrous tissue and 
separated from the surrounding living tissue. Such biological response is known as a nor-
mal immune reaction of the living body with respect to exogenous materials. In early 1970s, 
L.L. Hench found that Na
2
O-CaO-SiO
2
-P
2
O
5
-type glass (bioglass®) showed bone-bonding abil-
ity without the isolation from surrounding living tissue [1]. Since the discovery of bioglass®, 
ceramic materials such as glass-ceramic Ceravital® containing crystalline apatite [2], sintered 
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hydroxyapatite (Ca10(PO4)6(OH)2) [3], glass-ceramics Cerabone® A-W containing crystalline apatite and wollastonite (CaO·SiO
2
) [4, 5], and so on have been found to bond with living 
bone. Most of the ceramics mentioned above forms apatite layer on their surface and can bond 
with living bone through the apatite layer in living body [6, 7]. This apatite layer consists of 
minute crystallites containing carbonate ions in chemical composition [8] and is similar to 
apatite, which contains living bone [9, 10]. On the apatite layer, osteoblast actively proliferates 
and differentiates [6, 11]. Hence, bone tissue is formed on the apatite layer and the artificial 
materials can be also found to bond with the surrounding bone tissue through the apatite 
layer. Such material property is often defined as ‘bioactivity’ in the research field of ceramic 
biomaterials.
1.2. Simulated body fluid
In early 1990s, T. Kokubo proposed an acellular simulated body fluid (SBF) with ion con-
centrations similar to those of human blood plasma [12–14]. It is possible to reproduce the 
abovementioned apatite formation reaction on most of the bioactive materials by soaking 
the materials in SBF. Hence, we can predict bioactivity, that is, apatite-forming ability, of 
specimens by soaking them in SBF and evaluating apatite formation on their surface. Table 1 
shows the ion concentrations of simulated body fluid and human blood plasma. The SBF 
can be prepared by dissolving NaCl, NaHCO
3
, KCl, K
2
HPO
4
·3H
2
O, MgCl
2
·6H
2
O, CaCl
2
 and 
Na
2
SO
4
 in pure water and maintaining the pH value at 7.40 with (CH
2
OH)
3
CNH
2
 and 1 mol 
dm−3 HCl solution at 36.5°C. The details of preparation method of SBF and the bioactivity test 
are certified by ISO 23317 [14]
1.3. Apatite nuclei
When pH and temperature of SBF are raised, fine particles of calcium phosphate are pre-
cipitated. Generally, calcium phosphate formation in an aqueous solution can be described as 
shown in (Eq. (1)) by applying hydroxyapatite as a representative calcium phosphate.
  10  Ca 2+ +  6PO 
4
 3− +  2OH −  =  Ca 10   ( PO 4 ) 6   (OH) 2 (1)
Ion Ion concentration/mM
SBF Blood plasma
Na+ 142.0 142.0
K+ 5.0 5.0
Mg2+ 2.5 2.5
Ca2+ 1.5 1.5
Cl− 147.8 103.0
HCO
3
− 4.2 27.0
HPO
4
2− 1.0 1.0
SO
4
2− 0.5 0.5
Table 1. Ion concentrations of simulated body fluid (SBF) and human blood plasma.
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When pH value or concentration of the aqueous solution increases, apatite formation is pro-
moted from a viewpoint of the abovementioned chemical equilibrium because of an increase of 
OH− or Ca2+ and PO
4
3−. In addition, the reaction is accelerated under high-temperature environ-
ment because of an increase of chemical reaction rate of calcium phosphate formation. Yao et al. 
found that thus-precipitated fine particles of calcium phosphate showed high activity for induc-
tion of porous bone-like apatite formation in SBF and named the particles ‘apatite nuclei’ [15].
1.4. Bioactive materials’ design by utilizing the function of apatite nuclei
As described in Section 1.3, apatite nuclei, precipitated by raising pH or temperature of SBF, 
actively induce apatite formation in SBF or body environment. By using apatite nuclei, excel-
lent implant materials possessing various mechanical properties as well as high bioactivity 
and bioaffinity can be developed by combining it with various kinds of bioinert materials 
such as metals and organic polymers. Recently, we found that high apatite-forming ability 
can be imparted by the following method [16].
• Micropores are formed on the surface of the substrate by acid treatment or sandblasting 
process.
• The abovementioned micropores-formed substrate or porous substrate is soaked in SBF, 
and pH and temperature of SBF is increased. By this treatment, apatite nuclei are precipi-
tated in the pores of the substrate.
When this material is implanted into a bone defect, it is thought that apatite nuclei induce 
apatite formation and this material subsequently bonds with living bone through the formed 
bone-like apatite layer (Figure 1). As a result, it is expected that the materials can bond with 
living bone through the formed apatite layer.
2. Fabrication of bioactive metals by incorporation of apatite nuclei as 
precursors of apatite
2.1. Bioactive metals
Metals have high mechanical strength and high fracture toughness. Among them, stain-
less used steel (SUS), cobalt-chromium (Co-Cr) alloys, titanium (Ti) and its alloys have 
Figure 1. Bioactive materials’ design by utilizing the function of apatite nuclei.
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been widely used as implant materials. However, most of them do not have bioactivity or 
have extremely poor bioactivity. Hence, these materials without any pretreatment cannot 
spontaneously form apatite coatings in living body in most cases. For this reason, effective 
methods for imparting high bioactivity to these metallic biomaterials are desired. As a rep-
resentative surface modification of metals for bioactivity, hydroxyapatite coating by plasma 
spray method has been widely used in practical use as artificial hip joint [17]. However, this 
method required heating process at a temperature over 10,000°C and it is difficult to optimize 
the composition and crystallinity of hydroxyapatite for the bone conduction in living body. 
Kokubo et al. reported that NaOH and heat treatment are an effective way to impart bioactiv-
ity to the surface of Ti metal and its alloys [5, 18, 19]. In fact, the NaOH- and heat-treated Ti 
metal showed apatite formation within 1 day in SBF and attained high bioactivity. From these 
properties, the Kokubo’s method has been already used in clinical use as a surface modifica-
tion for artificial hip joint. However, this method cannot be applied to SUS and Co-Cr alloys 
[19]. As one of the most effective method for solving this problem, incorporation of apatite 
nuclei described in Section 1.4 can become an effective candidate to impart bioactivity to 
various kinds of bioinert metallic biomaterials. Recently, the author successfully imparted 
bioactivity to pure Ti metal [20–22], Ti-6Al-4 V alloy [23], Ti-15Mo-5Zr-3Al alloy [22, 24, 25], 
Ti-12Ta-9Nb-3 V-6Zr-O alloy [22], pure zirconium (Zr) metal [23], Co-Cr alloy [26] and SUS 
[27, 28] by incorporation of apatite nuclei on their surfaces based on the materials’ design 
described in Section 1.4. Among them, the author introduces the details of bioactive SUS as a 
representative case of bioinert metallic biomaterials in this chapter.
2.2. SUS as an orthopedic material
SUS is a typical biomaterial with high mechanical strength and high-corrosion resistance and 
has been already used as orthopedic implants such as artificial hip joint. However, SUS has no 
bioactivity. If an effective bioactivity treatment for SUS is established, range of its application 
is largely extended. Bioactivity treatment utilizing apatite nuclei described in Section 1.4 is one 
of the effective methods used for surface modification of SUS to impart bioactivity. As a novel 
micropores formation process, the authors established a formation process of roughened sur-
face with fine pores on metals and organic polymers by doubled sandblasting process [29] by 
using the grinding particles with 14 μm of average particle size as first process, and then using 
the particles with 3 μm of average particle size as second process. The authors clarified that 
thus-formed fine pores contributed to the improvement of adhesion property of porous bone-
like apatite layer formed on the bioactive materials in SBF in the process shown in Figure 1 
because of an improvement of mechanical interlocking effect. As described in this section, the 
authors formed micropores on the surface of SUS plates by the doubled sandblasting process. 
Then the authors precipitated apatite nuclei in the pores of SUS to impart bioactivity.
2.3. Fabrication process of bioactive SUS
2.3.1. Micropores formation by the doubled sandblasting process
First, in order to prepare micropores on the surface, the SUS plates (JIS SUS 316 L) were 
treated by a sandblasting process using alumina-grinding particles with 14 μm (JIS #800) of 
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average particle size. Then, the plates were treated by that with 3 μm (JIS #4000) of average 
particle size. Figure 2 shows the SEM micrograph of the surface of the SUS plate after the 
sandblasting process. It can be seen that the SUS plate possessed the roughened surface with 
fine pores formed by the sandblasting process.
2.3.2. Impartation of apatite-forming ability: incorporation of apatite nuclei as precursors of apatite
After the micropores formation, the following process was conducted for apatite nuclei precipi-
tation in the pores to impart bioactivity to the surface of the SUS plate. First, the pH value of SBF 
was increased to 8.40 by dissolving tris(hydroxymethyl)aminomethane at 25°C. Subsequently, 
the SUS plates were soaked in the SBF and the solution was pressed by cold isostatic pressing 
machine to make the solution penetrate into the pores. In order to precipitate apatite nuclei in the 
pores of the specimens, the solution was heated by using electromagnetic induction at 2.5 kW 
for 2 hours while soaking the specimens in the solution. Hereafter, the authors denote these 
treatments as ‘alkaline SBF treatment’. Figure 3 shows the SEM micrograph and the EDX profile 
of the surface of the SUS plate after the alkaline SBF treatment. It can be seen that the surface 
morphologies were slightly rounded off in comparison with just after the doubled sandblasting 
process shown in Figure 2 and some types of coatings were formed on the plates. In the EDX 
profile, peaks of P and Ca were detected. It is considered that the SUS plate has been effectively 
heated in SBF by electromagnetic induction because the iron, which is a main chemical com-
ponent of SUS, has high magnetic susceptibility. As a result, nucleation and growth of calcium 
phosphate were further promoted and the apatite nuclei formed under alkaline condition grew 
to some types of calcium phosphate coating on the surface of the SUS plate in the alkaline SBF 
treatment. Hereafter, the SUS plate after the alkaline SBF treatment is denoted as ‘bioactive SUS’
2.4. Apatite-forming ability of bioactive SUS: porous bone-like apatite coatings  
in biomimetic environment
Next, bioactivity of thus-obtained bioactive SUS was evaluated by soaking in SBF at pH 7.40, 
36.5°C, which is corresponded to physiological environment. Figure 4 shows the thin-film 
Figure 2. SEM micrograph of the surface of the SUS plate after the sandblasting process.
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X-ray diffraction (TF-XRD) profiles of the surface of the bioactive SUS after soaking in SBF for 
0 day (i.e., before soaking in SBF), 1 day, 3 days and 7 days. Before soaking in SBF, diffraction 
peaks of apatite were not detected. This result suggested that the calcium phosphate coating 
formed in the alkaline SBF treatment was consisted of amorphous calcium phosphate (ACP). 
After soaking in SBF for 1 day, 3 days and 7 days, diffraction peaks of apatite were clearly 
detected. Figure 5 shows the SEM micrograph and the EDX profile of the surface of the bioac-
tive SUS after soaking in SBF for 1 day. It was observed that the whole surface was covered 
with porous coating, which consisted of needle-like crystallites, which characterize bone-like 
apatite, in the SEM observation. In the EDX profile, the intensity of the peaks of P and Ca 
was relatively increased in comparison with those after the alkaline SBF treatment shown in 
Figure 3. From these results, it is indicated that apatite formation was induced within 1 day 
and high bioactivity was imparted to the SUS by the alkaline SBF treatment.
Figure 4. TF-XRD profile of the surface of the bioactive SUS after the soaking in SBF for 0 day, 1 day, 3 days and 7 days.
Figure 3. (a) SEM micrograph and (b) EDX profile of the surface of the SUS plate after the alkaline SBF treatment.
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2.5. Adhesion property of porous bone-like apatite coating formed on the bioactive SUS
The adhesive strength between the bioactive SUS and the porous bone-like apatite coating 
formed by soaking in SBF for 14 days was measured by a modified ASTM C-633 method 
[30–33]. For the reference, the author prepared the specimens, which were applied same treat-
ments without the doubled sandblasting treatment. The average adhesive strength between 
the formed apatite layer and the bioactive SUS with alkaline SBF treatment was 15.4 MPa, and 
for the SUS without the sandblasting treatment was 1.5 MPa. The SUS treated with doubled 
sandblasting treatment showed higher adhesive strength than untreated ones. This is because 
a mechanical interlocking effect between the SUS plate and the porous bone-like apatite coat-
ing was attained by the formation of micropores.
2.6. Case of the other types of metals
As described in Section 2.1, the author reported that this bioactivity treatment was applicable 
not only to SUS but also to other kinds of metallic biomaterials such as Ti metal and its alloys, 
Zr metal and Co-Cr alloy by optimizing the condition of micropores formation and apatite 
nuclei precipitation according to the kinds of materials. Also in the case of these metals, apa-
tite formation was induced within 1 day in SBF [20–26]. In addition, it is reported that most 
of the bioactive ceramics show apatite formation within 1 week in SBF [34]. Hence, it is sug-
gested that the alkaline SBF treatment was an effective method to impart high bioactivity to 
bioinert or poorly bioactive metals.
3. Fabrication of bioactive organic polymers by incorporation of apatite 
nuclei as precursors of apatite
3.1. Bioactive organic polymers
Organic polymers have various mechanical properties and are easily processed in various 
shapes such as sticks, plates, films, sponges and fibers. Because of these properties, organic 
polymers have been widely used as various implant materials such as artificial hip joint, 
Figure 5. (a) SEM micrograph and (b) EDX profile of the surface of the bioactive SUS after the soaking in SBF for 1 day.
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artificial knee joint, artificial knuckle joint and artificial ligament. Generally, however, 
organic polymers are not bioactive and cannot bond with living bone in living body. If 
organic polymers acquire bioactivity, implant materials with various mechanical prop-
erties as well as high bioactivity can be developed. As a conventional method to impart 
bioactivity to organic polymers, the method that bioactive ceramics particles such as sin-
tered hydroxyapatite are dispersed in polymeric matrix have been mainly applied. Among 
them, HAPEX™, which contains 40 vol% of hydroxyapatite in high density polyethylene 
matrix [35], has been already in practical use as an orbital implant and a middle ear implant. 
However, such method is difficult to control bioactivity of the materials because most of 
ceramics particles are buried inside the polymeric matrix and bioactivity was performed by 
only the particles exposed to the surface of the materials [36]. As one of the most effective 
method for solving this problem, the alkaline SBF treatment described in Section 1.4 can act 
as an attractive candidate to impart bioactivity also to polymeric biomaterials, similar to the 
case of metals. Recently, the author successfully established the surface modification tech-
nique to impart bioactivity to ultrahigh-molecular weight polyethylene (UHMWPE) [37], 
polyethyleneterephthalate (PET) [24], poly-l-lactic acid (PLLA) [38], polyetheretherketone 
(PEEK) [39–41], carbon fiber-reinforced PEEK (CFR-PEEK) [42], glass fiber-reinforced PEEK 
(GFR-PEEK) [42] and glass fiber-reinforced poly(m-Xylyleneadipamide)-6 (GFR-MXD6) 
[43]. Among them, the author introduces the details of bioactive PEEK as representative 
cases of polymeric biomaterials in this chapter.
3.2. PEEK as orthopedic materials
PEEK is well known as one of the next-generation polymeric materials with high mechani-
cal toughness. In addition, PEEK is in the spotlight of orthopedic or dental fields because 
of its more similar elastic modulus with cortical bone than metallic biomaterials such 
as Ti alloys, SUS and Co-Cr alloys and ceramic biomaterials such as alumina, zirconia 
and sintered hydroxyapatite. From these mechanical properties, it is expected that PEEK 
becomes a candidate for replacing conventional metallic or ceramic bone substitutes in 
clinical use [44]. Although PEEK has biocompatibility, bioactivity of PEEK is extremely 
poor. If high bioactivity is imparted to PEEK, the range of its clinical or dental use such 
as minimally invasive orthopedic treatment will be largely extended. As described in this 
section, micropores were formed on PEEK by sulfuric acid treatment. Then apatite nuclei 
were precipitated in the pores and bioactivity was imparted to PEEK by incorporation of 
apatite nuclei.
3.3. Fabrication process of bioactive PEEK
3.3.1. Micropores formation by sulfuric acid treatment
First, in order to form micropores on the surface of the PEEK, PEEK plates were treated with 
98% sulfuric acid at room temperature. Figure 6 shows the SEM micrograph of the surface of 
the PEEK after the sulfuric acid treatment. It can be seen that cancellous micropores around 
500 nm in diameter were formed on the whole surface of the plate.
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3.3.2. Impartation of apatite-forming ability: incorporation of apatite nuclei as precursors of apatite
Next, the author conducted surface modification to impart bioactivity to PEEK by incorpora-
tion of apatite nuclei. As a pretreatment for the apatite nuclei incorporation, the surfaces of 
the micropores-formed PEEK were treated with glow-discharge in O
2
 gas atmosphere. By this 
treatment, reactive functional groups, which have hydrophilic property, were supplied on 
the surfaces of organic polymers [45]. The pH value of SBF was increased to 8.4 by dissolving 
tris(hydroxymethyl)aminomethane at 25°C. In order to precipitate apatite nuclei in the micro-
pores, the micropores-formed PEEK was soaked in this SBF and kept at 70°C for 24 hours. 
Hereafter, this treatment is denoted as ‘alkaline SBF treatment’. Figure 7 shows the SEM 
micrograph and the EDX profile of the surface of the micropores-formed PEEK after the alka-
line SBF treatment. It can be seen that the surface morphology was different from Figure 6, 
after the sulfuric acid treatment. In the EDX profile, peaks of P and Ca were detected. In the 
SEM micrograph, spherical particles of apatite nuclei were observed on the whole surface. It 
is considered that apatite nuclei were precipitated on the surface or inside the pores by the 
alkaline SBF treatment. Hereafter, this material is denoted as ‘bioactive PEEK’
3.4. Apatite-forming ability of bioactive PEEK: formation of porous bone-like apatite 
coatings in biomimetic environment
Next, bioactivity of the bioactive PEEK was evaluated by SBF test similar to the case of SUS 
as described in Section 2.4. Figure 8 shows the TF-XRD profiles of the surface of the bioactive 
PEEK after the soaking in SBF for 0 day, 1 day, 3 days, 7 days and 14 days. After soaking in 
SBF for 1 day, diffraction peaks of apatite were detected. As elapse of soaking time, the inten-
sity of the diffraction peaks increased and those of PEEK decreased. Figure 9 shows the SEM 
micrograph and the EDX profile of the surface of the bioactive PEEK after soaking in SBF for 
1 day. It can be seen that the whole surface of the plate was covered with porous coatings con-
sisted of needle-like crystallites, which characterize bone-like apatite, in the SEM observation 
Figure 6. SEM micrograph of the surface of the PEEK plate after the sulfuric acid treatment.
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and peaks of P and Ca were strongly detected in the EDX analysis. By considering the results 
of TF-XRD, SEM and EDX, it is revealed that porous bone-like apatite, which was induced by 
apatite nuclei, covered the whole surface of the bioactive PEEK within 1 day and the apatite 
layer grew thick as elapse of the soaking time.
3.5. Adhesion property of porous bone-like apatite coating formed on the  
bioactive PEEK
Similar to the case of metals, adhesive strength between the bioactive PEEK and the porous 
bone-like apatite coating formed by soaking in SBF for 14 days was measured by a modified 
ASTM C-633 method [30–33]. For the reference, the author prepared the specimens, which 
Figure 7. (a) SEM micrograph and (b) EDX profile of the surface of the PEEK plate after the alkaline SBF treatment.
Figure 8. TF-XRD profiles of the surface of the untreated PEEK and the bioactive PEEK after the soaking in SBF for 0 day, 
1 day, 3 days, 7 days and 14 days.
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were applied same treatments without sulfuric acid treatment. The average value of adhesion 
strength of the porous bone-like apatite coating for the bioactive PEEK with the pores formed 
by the sulfuric acid treatment was 6.7 MPa. In contrast, PEEK without pores formation was 
2.1 MPa. The PEEK with pores formed by the sulfuric acid treatment presented higher adhe-
sion strength. This difference was caused by a mechanical interlocking effect between the PEEK 
and porous bone-like apatite layer by existence of the micropores, similar to the case of the SUS.
3.6. Case of the other types of polymers
As described in Section 2.1, the author reported that this bioactivity method was applicable not 
only to PEEK but also to other kinds of polymeric biomaterials such as UHMWPE, PET, PLLA, 
CFR-PEEK, GFR-PEEK and GFR-MXD6 by optimizing the condition of micropores formation 
and apatite nuclei precipitation according to the kinds of materials, similar to the case of the met-
als [24, 37, 38, 42, 43]. Also in the case of these polymers, apatite formation was induced within 
1 day in SBF in most cases. Hence, it is suggested that the alkaline SBF treatment was an effective 
method to impart high bioactivity not only to metals but also to polymeric implant materials.
4. Fabrication of apatite microcapsules consisted of biomimetic porous 
bone-like apatite coatings by using apatite nuclei as precursors of apatite
4.1. Fabrication of microcapsule consisted of porous bone-like apatite
Drug delivery system (DDS) is one of the most attractive techniques in the medical and pharma-
ceutical fields. DDS can contributes to chemotherapy that can achieve low side effects because it 
can achieve an efficient local or controlled release of pharmaceutical drugs. The microcapsules 
can be filled with pharmaceutical drugs. Hence, the DDS carriers consisted of microcapsules have 
a possibility to be applied in many kinds of pharmaceutical fields. Apatite has high bioaffinity 
because it forms bone-like apatite coatings consisted of needle-like fine crystallites on its surface 
in living body and can avoid immune reaction. From the above idea, it is thought that microcap-
sules possessing high biocompatibility can be obtained by applying apatite. The porous bone-like 
apatite microcapsules can be fabricated by the following process [46, 47]:
Figure 9. (a) SEM micrograph and (b) EDX profile of the surface of the bioactive PEEK after the soaking in SBF for 1 day. 
The generation of cracks observed in Figure 9 (a) was caused when the specimen was air-dried after the SBF test.
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• Apatite nuclei are attached to the surfaces of core particles.
• The microspheres are soaked in SBF.
By this treatment, apatite formation is induced by the apatite nuclei and grows over the whole 
surface area of the core particles. As a result, porous bone-like apatite coats the whole surface of 
the particles and apatite microcapsules can be obtained (Figure 10). By this method, it is expected 
to encapsulate various kinds of functional particles or pharmaceutical drugs with apatite.
The development of sustained-release of drug is expected to contribute to have effects of the 
drug without side effects and reduce the burdens of patients. Porous bone-like apatite formed 
in SBF has flake-like crystalline structure and porous body [46, 47]. Focusing on these features 
of porous bone-like apatite, the author has intended to fabricate porous bone-like apatite 
microcapsules encapsulating various kinds of substances such as PLLA [48], silver [48], silica 
gel [48, 49], magnetite [50], maghemite [51, 52], agarose gel [53, 54] and corn oil [55]. Among 
them, the author introduces the details of encapsulation of corn oil in the porous bone-like 
apatite microcapsules as representative cases in this chapter.
4.2. Porous bone-like apatite microcapsules encapsulating corn oil
By utilizing surfactant such as albumin, oil droplets in micrometer level can be stabilized in 
water phase or water droplets in micrometer level can be stabilized in oil phase. The micro-
encapsulation techniques by forming oil or water droplets can achieve an intravenous injec-
tion of the droplets containing pharmaceutical drug. As described in this section, the author 
fabricated porous bone-like apatite microcapsules encapsulating corn oil droplets containing 
ibuprofen, hydrophobic drug and nonsteroidal anti-inflammatory drug and evaluated the 
temporal change in release of the ibuprofen in vitro.
4.3. Preparation process of porous bone-like apatite microcapsules encapsulating  
corn oil
4.3.1. Fabrication of porous bone-like apatite microcapsules
Corn oil and ibuprofen were mixed. In order to dissolve ibuprofen in corn oil sufficiently, 
ethyl acetate was added in the mixture. After albumin aqueous solution was poured, the mix-
ture was treated by ultrasonic vibration, so emulsion was formed. The emulsion was mixed 
Figure 10. Fabrication process of apatite microcapsules by using apatite nuclei.
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with 1.5 SBF, whose ion concentrations are 1.5 times in comparison with those of SBF, and 
apatite nuclei, thereafter, the mixture was treated by ultrasonic vibration to attach apatite 
nuclei on the surface of the oil droplets. After ethyl acetate was evaporated and removed from 
the mixture, the solution was kept at 36.5°C for 4 days. Figure 11 shows SEM micrograph 
and EDX profile of thus-obtained microcapsules. Spherical particles consisted of needle-like 
crystals, which characterize bone-like apatite, were observed. In the EDX measurement, phos-
phorus and calcium, main consistent of apatite, were detected. It is suggested that the apatite 
nuclei attached on the oil droplets induced formation of bone-like apatite and then the crystal 
growth of apatite was caused on the surface of the oil droplets. Figure 12 shows the powder 
X-ray diffraction (XRD) profile of the obtained apatite microcapsules. It can be seen that the 
peak positions of the apatite microcapsules corresponded to those of apatite, but shape of the 
pattern was broad. From this result, it was indicated that bone-like apatite covered the corn 
oil droplets during soaking in SBF.
4.4. Function of porous bone-like apatite microcapsules: drug release behavior
The author evaluated the release behavior of ibuprofen contained in corn oil droplets. 
Figure 13 shows the temporal change in the concentration of ibuprofen released from 
porous bone-like apatite microcapsules in phosphate buffer (pH 7.40 at 36.5°C) measured by 
high-performance liquid chromatography (HPLC). It can be seen that the concentration of 
Figure 11. (a) SEM micrograph and (b) EDX profile of the porous bone-like apatite microcapsules encapsulating corn oil.
Figure 12. XRD profile of the porous bone-like apatite microcapsules encapsulating corn oil.
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ibuprofen in the buffer did not increase rapidly in a short time but increased gradually. This 
profile suggested that the porous structure of bone-like apatite microcapsules can gradually 
release ibuprofen contained in corn oil through the micropores of the apatite coatings.
4.5. Other types of porous bone-like apatite microcapsules
As described in Section 4.1, this fabrication method for porous bone-like apatite microcapsules 
was applicable to other kinds of core materials such as encapsulating various kinds of substance 
such as PLLA [48], silver [48], silica gel [48, 49], magnetite [50], maghemite [51, 52] and agarose 
gel [53, 54] by optimizing the fabrication condition. In the case of silver, sustained release of 
silver was attained by existence of porous coatings of bone-like apatite. In the case of silica gel, 
sustained release of insulin was attained by conducting absorption of insulin solution into the 
silica-gel matrix [56]. In the case of magnetite, release of magnetite was inhibited in water by 
existence of the porous apatite coatings. In the case of agarose gel, sustained release of vitamin 
B12 was attained by conducting insertion of vitamin B12 solution in the apatite microcapsules [53]. In the case of maghemite, in addition, the author successfully achieved enzyme immobilization 
and collection by combination of bioaffinity of apatite with ferrimagnetism of maghemite.
5. Conclusion
In this chapter, the author introduced novel biomaterials utilizing porous bone-like apatite 
formation from apatite nuclei from a viewpoint of bioactive metals, bioactive organic poly-
mers and apatite microcapsules. This methodology has high materials selectivity, and func-
tion of apatite nuclei enables us to impart bioactivity to various kinds of materials or to coat 
microparticles with porous bone-like apatite coating. It is expected that the porous bone-like 
apatite coating technique are promising methodology to be useful to fabricate novel medical, 
pharmaceutical and environmental materials by combination of bone-like apatite with vari-
ous kinds of functional materials in micron scale.
Figure 13. Release behavior of ibuprofen from bone-like apatite microcapsules.
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